Crestchem Limited (CRSTCHM.BO)
INR 223.4
(4.98%)
INR 223.4
(4.98%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 30.33 Million INR | 185.68% |
| 2022 | 9.7 Million INR | 17.86% |
| 2021 | 8.22 Million INR | 15.59% |
| 2020 | 7.13 Million INR | 19.77% |
| 2019 | 5.94 Million INR | 501.13% |
| 2018 | -1.48 Million INR | 30.99% |
| 2017 | -2.14 Million INR | -81.12% |
| 2016 | -1.18 Million INR | -188.25% |
| 2015 | 1.34 Million INR | 244.7% |
| 2014 | 7.48 Million INR | -213.71% |
| 2013 | 819.4 Thousand INR | 147.41% |
| 2012 | 242.59 Thousand INR | -28.67% |
| 2011 | 1.29 Million INR | -11232.69% |
| 2010 | 12.02 Thousand INR | 100.8% |
| 2009 | -1.49 Million INR | -967.75% |
| 2008 | 258.72 Thousand INR | 119.46% |
| 2007 | -887.77 Thousand INR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 7.58 Million INR | -10.62% |
| 2023 Q3 | 12.26 Million INR | 159.78% |
| 2023 Q2 | 4.72 Million INR | 45.8% |
| 2023 Q1 | 3.23 Million INR | 245.2% |
| 2023 FY | - INR | 185.68% |
| 2023 Q4 | 8.53 Million INR | -30.42% |
| 2022 Q1 | 2 Million INR | -47.21% |
| 2022 FY | - INR | 17.86% |
| 2022 Q3 | 4.94 Million INR | 173.36% |
| 2022 Q4 | 938 Thousand INR | -81.03% |
| 2022 Q2 | 1.8 Million INR | -9.91% |
| 2021 Q1 | 1.58 Million INR | -49.54% |
| 2021 Q3 | 3.27 Million INR | 841.18% |
| 2021 FY | - INR | 15.59% |
| 2021 Q2 | -442 Thousand INR | -127.9% |
| 2021 Q4 | 3.8 Million INR | 16.12% |
| 2020 FY | - INR | 19.77% |
| 2020 Q4 | 3.13 Million INR | 1501.51% |
| 2020 Q3 | 196 Thousand INR | -93.19% |
| 2020 Q2 | 2.88 Million INR | 218.58% |
| 2020 Q1 | 904 Thousand INR | -71.17% |
| 2019 Q1 | -696 Thousand INR | -73.58% |
| 2019 Q3 | 1.8 Million INR | 6.12% |
| 2019 Q4 | 3.13 Million INR | 73.81% |
| 2019 Q2 | 1.7 Million INR | 344.25% |
| 2019 FY | - INR | 501.13% |
| 2018 Q3 | -208 Thousand INR | -67.74% |
| 2018 FY | - INR | 30.99% |
| 2018 Q4 | -400.96 Thousand INR | -92.77% |
| 2018 Q2 | -124 Thousand INR | 83.47% |
| 2018 Q1 | -750 Thousand INR | -22.48% |
| 2017 Q3 | -623 Thousand INR | -79.02% |
| 2017 Q4 | -612.32 Thousand INR | 1.71% |
| 2017 FY | - INR | -81.12% |
| 2017 Q1 | -282 Thousand INR | -77.36% |
| 2017 Q2 | -348 Thousand INR | -23.4% |
| 2016 Q4 | -159 Thousand INR | 36.65% |
| 2016 Q3 | -251 Thousand INR | 55.73% |
| 2016 Q2 | -567 Thousand INR | -183.5% |
| 2016 FY | - INR | -188.25% |
| 2016 Q1 | -200 Thousand INR | -152.91% |
| 2015 Q4 | 378 Thousand INR | 529.55% |
| 2015 Q1 | 1.11 Million INR | 113.14% |
| 2015 Q2 | -63 Thousand INR | -105.64% |
| 2015 FY | - INR | 244.7% |
| 2015 Q3 | -88 Thousand INR | -39.68% |
| 2014 Q4 | -8.49 Million INR | -206.91% |
| 2014 Q2 | -343 Thousand INR | -268.82% |
| 2014 Q1 | -93 Thousand INR | -109.74% |
| 2014 FY | - INR | -213.71% |
| 2014 Q3 | 7.95 Million INR | 2417.78% |
| 2013 FY | - INR | 147.41% |
| 2013 Q2 | -388 Thousand INR | -7.78% |
| 2013 Q4 | 954.4 Thousand INR | 55.69% |
| 2013 Q3 | 613 Thousand INR | 257.99% |
| 2013 Q1 | -360 Thousand INR | -118.31% |
| 2012 Q4 | 1.96 Million INR | 345.76% |
| 2012 Q1 | -302 Thousand INR | -87.41% |
| 2012 FY | - INR | -28.67% |
| 2012 Q2 | -325 Thousand INR | -7.62% |
| 2012 Q3 | -800 Thousand INR | -146.15% |
| 2011 Q3 | -135 Thousand INR | 0.0% |
| 2011 Q4 | -161.14 Thousand INR | -19.37% |
| 2011 FY | - INR | -11232.69% |
| 2010 FY | - INR | 100.8% |
| 2009 FY | - INR | -967.75% |
| 2008 FY | - INR | 119.46% |
| 2007 FY | - INR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Sunil Healthcare Limited | 93.07 Million INR | 67.41% |
| ANG Lifesciences India Limited | 90.66 Million INR | 66.541% |
| BDH Industries Limited | 124.27 Million INR | 75.591% |
| Deccan Health Care Limited | 37.5 Million INR | 19.121% |
| DECIPHER LABS LIMITED | -2.72 Million INR | 1215.233% |
| Gujarat Themis Biosyn Limited | 830.99 Million INR | 96.35% |
| Hindustan Bio Sciences Limited | 638.75 Thousand INR | -4648.985% |
| Ishita Drugs and Industries Limited | 11.88 Million INR | -155.168% |
| Jenburkt Pharmaceuticals Limited | 377.86 Million INR | 91.972% |
| KIMIA BIOSCIENCES LIMITED | 11.58 Million INR | -161.864% |
| MedPlus Health Services Limited | 3.94 Billion INR | 99.23% |
| Patidar Buildcon Limited | -5.52 Million INR | 648.938% |
| Add-Shop E-Retail Limited | 82.61 Million INR | 63.282% |
| Bacil Pharma Limited | -569.32 Thousand INR | 5428.169% |
| Beryl Drugs Limited | 26.63 Million INR | -13.872% |
| Cian Healthcare Limited | 122.56 Million INR | 75.251% |
| Concord Drugs Limited | 40.52 Million INR | 25.137% |
| Sanjivani Paranteral Limited. | 87.58 Million INR | 65.365% |
| Gujarat Terce Laboratories Limited | 15.87 Million INR | -91.058% |
| Sastasundar Ventures Limited | -203.51 Million INR | 114.905% |
| SHAMROCK INDUSTRIAL CO.LTD. | -406 Thousand INR | 7571.51% |
| Source Natural Foods and Herbal Supplements Limited | 44.8 Million INR | 32.295% |
| SUDARSHAN PHARMA INDUSTRIES LI | 254.17 Million INR | 88.065% |
| Syschem (India) Limited | 70.4 Million INR | 56.912% |
| Medi-Caps Limited | 4.77 Million INR | -535.807% |
| Parmax Pharma Limited | 22.93 Million INR | -32.248% |
| Smruthi Organics Limited | 120.31 Million INR | 74.787% |
| Phaarmasia Limited | -1.58 Million INR | 2017.467% |
| Transchem Limited | 56.61 Million INR | 46.416% |
| Trinity League India Limited | -26.25 Million INR | 215.546% |
| Tyche Industries Limited | 128.2 Million INR | 76.34% |
| Vista Pharmaceuticals Limited | -32.37 Million INR | 193.685% |
| Zenith Healthcare Limited | 4.98 Million INR | -508.146% |
| Chemo Pharma Laboratories Limited | 16.51 Million INR | -83.644% |
| Colinz Laboratories Limited | 5.42 Million INR | -458.849% |
| Denis Chem Lab Limited | 224.84 Million INR | 86.509% |
| Kwality Pharmaceuticals Limited | 610.44 Million INR | 95.031% |
| Makers Laboratories Limited | 25.81 Million INR | -17.52% |
| Panchsheel Organics Limited | 189.36 Million INR | 83.981% |
| Parnax Lab Limited | 243.59 Million INR | 87.547% |
| PRAVEG LIMITED | 321.43 Million INR | 90.563% |
| Mercury Laboratories Limited | 101.18 Million INR | 70.022% |
| Trident Lifeline Limited | 102.69 Million INR | 70.461% |
| Vikram Thermo (India) Limited | 386.92 Million INR | 92.16% |
| Vivanza Biosciences Limited | 11.2 Million INR | -170.746% |
| Zenlabs Ethica Limited | 27.09 Million INR | -11.951% |
| SHELTER PHARMA LIMITED | 89.01 Million INR | 65.92% |
| Vasundhara Rasayans Limited | 84.22 Million INR | 63.985% |
| Bharat Immunologicals & Biologicals Corporation Limited | -151.05 Million INR | 120.082% |
| Roopa Industries Limited | 55.7 Million INR | 45.541% |
| PANJON LTD. | 4.08 Million INR | -641.852% |
| Pharmaids Pharmaceuticals Limited | -123.28 Million INR | 124.606% |
| TIAAN CONSUMER LIMITED | -19.05 Million INR | 259.219% |
| Anuh Pharma Limited | 878.5 Million INR | 96.547% |
| Emmessar Biotech & Nutrition Limited | -10.81 Million INR | 380.406% |
| Sandu Pharmaceuticals Limited | 27.19 Million INR | -11.552% |
| Fredun Pharmaceuticals Limited | 388.97 Million INR | 92.202% |
| Trimurthi Limited | -2.47 Million INR | 1323.894% |
| Shukra Pharmaceuticals Limited | 216.59 Million INR | 85.995% |
| Norris Medicines Limited | -1.78 Million INR | 1800.217% |
| Veerhealth Care Limited | 15.99 Million INR | -89.649% |
| Lactose (India) Limited | 201.22 Million INR | 84.925% |
| OXYGENTA PHARMACEUTICAL LIMITE | -96.17 Million INR | 131.542% |
| Ambalal Sarabhai Enterprises Limited | 170.57 Million INR | 82.216% |
| Gennex Laboratories Limited | 219.35 Million INR | 86.171% |
| Godavari Drugs Limited | 134.62 Million INR | 77.468% |
| Zenotech Laboratories Limited | 172.64 Million INR | 82.43% |
| Shree Ganesh Remedies Limited | 448.77 Million INR | 93.241% |
| Bharat Parenterals Limited | 265.74 Million INR | 88.585% |
| Coral Laboratories Limited | 227.07 Million INR | 86.641% |
| Evoq Remedies Limited | 6.18 Million INR | -390.214% |
| Kerala Ayurveda Limited | 70.78 Million INR | 57.147% |
| KOBO BIOTECH LIMITED | -8.57 Million INR | 453.836% |
| Natural Capsules Limited | 219.9 Million INR | 86.205% |
| Auro Laboratories Limited | 121.73 Million INR | 75.082% |